Department of Immunobiology, School of Medicine, UdelaR, 11800 Montevideo, Uruguay.
Int J Oncol. 2013 Sep;43(3):775-84. doi: 10.3892/ijo.2013.2000. Epub 2013 Jun 28.
There is substantial evidence suggesting that certain parasites can have antitumor properties. We evaluated mucin peptides derived from the helminth Echinococcus granulosus (denominated Egmuc) as potential inducers of antitumor activity. We present data showing that Egmuc peptides were capable of inducing an increase of activated NK cells in the spleen of immunized mice, a fact that was correlated with the capacity of splenocytes to mediate killing of tumor cells. We demonstrated that Egmuc peptides enhance LPS-induced maturation of dendritic cells in vitro by increasing the production of IL-12p40p70 and IL-6 and that Egmuc-treated DCs may activate NK cells, as judged by an increased expression of CD69. This evidence may contribute to the design of tumor vaccines and open new horizons in the use of parasite-derived molecules in the fight against cancer.
有大量证据表明,某些寄生虫可能具有抗肿瘤特性。我们评估了源自寄生虫棘球绦虫(Echinococcus granulosus)的粘蛋白肽(称为EgMuc),作为潜在的抗肿瘤活性诱导剂。我们提供的数据表明,EgMuc 肽能够诱导免疫小鼠脾脏中激活的 NK 细胞增加,这一事实与脾细胞介导肿瘤细胞杀伤的能力相关。我们证明,EgMuc 肽通过增加 IL-12p40p70 和 IL-6 的产生,增强 LPS 诱导的树突状细胞在体外的成熟,并且 EgMuc 处理的 DC 可以激活 NK 细胞,这可以通过 CD69 的表达增加来判断。这一证据可能有助于肿瘤疫苗的设计,并为寄生虫衍生分子在抗癌中的应用开辟新的前景。